Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
作者信息
Hamann U, Liu X, Lange S, Ulmer H U, Benner A, Scott R J
出版信息
J Med Genet. 2002 Mar;39(3):E12. doi: 10.1136/jmg.39.3.e12.
Abstract
摘要
相似文献
1
Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
J Med Genet. 2002 Mar;39(3):E12. doi: 10.1136/jmg.39.3.e12.
2
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Cancer Lett. 2002 Nov 8;185(1):61-70. doi: 10.1016/s0304-3835(01)00845-x.
3
The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.
Am J Hum Genet. 1999 Oct;65(4):1021-9. doi: 10.1086/302583.
4
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Neoplasma. 2006;53(2):97-102.
5
Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
J Med Genet. 1998 Feb;35(2):116-21. doi: 10.1136/jmg.35.2.116.
6
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Int J Cancer. 2006 Dec 15;119(12):2832-9. doi: 10.1002/ijc.22269.
7
[Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Arch Inst Pasteur Tunis. 2000;77(1-4):11-5.
8
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
J Clin Oncol. 2001 Apr 15;19(8):2247-53. doi: 10.1200/JCO.2001.19.8.2247.
9
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Bull Cancer. 2014 Nov;101(11):E36-40. doi: 10.1684/bdc.2014.2049.
10
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.
J Med Genet. 2002 Aug;39(8):611-4. doi: 10.1136/jmg.39.8.611.
引用本文的文献
1
Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.
Int J Oncol. 2012 Nov;41(5):1619-27. doi: 10.3892/ijo.2012.1595. Epub 2012 Aug 21.
2
Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.
Fam Cancer. 2010 Dec;9(4):507-17. doi: 10.1007/s10689-010-9372-3.
3
Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.
Hered Cancer Clin Pract. 2004 Jul 15;2(3):139-45. doi: 10.1186/1897-4287-2-3-139.
4
Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India.
J Cancer Res Clin Oncol. 2007 Nov;133(11):867-74. doi: 10.1007/s00432-007-0229-6. Epub 2007 May 15.
Zotero 插件